Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Sep 2, 2026

Press release

Bayesian Health's FDA-Cleared Continuous AI Sepsis Monitor Approved for Medicare New Technology Add-on Payment (NTAP)

Beginning October 1, 2026, hospitals using Bayesian's continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring.NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Bayesian Health today announced that its FDA-cleared sepsis flagging device has been approved for a New Technology Add-on Payment (NTAP) under the Centers for Medicare and Medicaid Services' FY 2027 Inpatient Prospective Paym
A vial of RNA on a lab bench with scientific equipment in the background.

Sep 2, 2026

US puts $125m into personalised RNA therapy production

The US Advanced Research Projects Agency for Health (ARPA-H) has allocated $125 million to enhance the production of customized RNA therapies through the Genetic Medicines and Individualised Manufacturing for Everyone (GIVE) initiative.This funding aims to transition from a traditional, centralized manufacturing model to a more efficient system designed for rapid production and accessibility. The GIVE program is expected to improve the availability of innovative treatments for various health con
Press release cover image

Sep 2, 2026

Press release

BC Platforms launches BC Mosaic App Store to empower data scientists and healthcare researchers with innovative analytics and workflow applications

Certified and integrated ecosystem within BC Mosaic helps healthcare and life sciences teams accelerate research and innovation by bringing specialized tools into BC Platforms' industry-leading trusted research environmentZURICH, Sept. 2, 2026 /PRNewswire/ -- BC Platforms today announced the launch of the BC Mosaic App Store, a certified ecosystem of specialized analytical and research applications. Through the BC Mosaic App Store, research teams can discover and easily access certified applicat
DNA helix and magnifying glass illustration

Sep 2, 2026

Deep-Learning Tool Uses Long-Read Sequencing to Detect Cancer Mutations

Researchers at The University of Hong Kong have introduced ClairS, a novel deep-learning tool that enhances the detection of cancer-related mutations using long-read sequencing technology.ClairS addresses the challenges of identifying low-frequency mutations in cancer cells, which are often difficult to analyze with traditional short-read sequencing methods. By leveraging long-read sequencing, the tool can more effectively map complex genomic regions that short-read technologies struggle with. T
Press release cover image

Sep 2, 2026

Press release

Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases

— Leveraging Cutting-Edge Causal AI-Based Digital Twins —Aitia’s Gemini Digital Twin (GDT) platform enables the inference of causal relationships to identify novel drug targets, which is not possible with conventional correlation-based AI. Each GDT is a virtual patient model that reflects the disease characteristics of real patients.GDTs are built by Aitia’s causal AI-based REFS™ technology, which is expected to be highly compatible with the discovery of novel therapeutic targets for neurologica
Press release cover image

Sep 2, 2026

Press release

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth.Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The co
Press release cover image

Sep 2, 2026

Press release

Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities

Co-authored IND submission preparation study results demonstrate ~97% reduction in time to first draft and 60% overall timeline compressionSAN FRANCISCO--(BUSINESS WIRE)--#AI--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaboration brings together Weave's AI capabilities and Takeda's regulatory expertise to support innovation in r
A vial of medication on a lab bench in a dimly lit pharmaceutical lab.

Sep 1, 2026

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech has introduced TraceIQ, a new enterprise traceability platform aimed at enhancing the operational efficiency of pharmaceutical and biopharma supply chains.TraceIQ represents a significant advancement from earlier traceability systems, which primarily focused on meeting serialization mandates and ensuring regulatory compliance. According to Sreedhar Patnala, Systech's general manager, while compliance remains crucial, it is not sufficient in today’s complex supply chain landscape. As regu
An upward arrow and stock chart symbolizing business growth

Sep 1, 2026

Veeva Systems (VEEV) Stock Climbed, What Is Behind The Fresh Attention?

Veeva Systems has recently garnered attention following its Q2 earnings report, updated guidance, and the introduction of new AI products, which have significantly impacted its stock performance.The company reported a strong second quarter, surpassing earnings expectations and securing global Vault CRM commitments from major biopharma clients like Biogen and Regeneron. This has coincided with a remarkable surge in Veeva's stock price, showing a 30-day return of over 40% and a 90-day return of mo
Press release cover image

Sep 1, 2026

Press release

Psychiatry Claims: September Malpractice Risk Review--Insights to Reduce Patient Harm and Malpractice Exposure

NAPA, Calif., Sept. 1, 2026 /PRNewswire/ -- The Doctors Company, the nation's largest physician-owned medical malpractice insurer, today released "Psychiatry Claims: September Malpractice Risk Review," the newest edition in a monthly series of specialty-focused analyses designed to support patient safety and clinical risk management.Each month in 2026, The Doctors Company will explore malpractice risk trends in a different medical specialty, offering evidence-based insights drawn from real claim
Press release cover image

Sep 1, 2026

Press release

SalesSparx and Augment Launch SAMI.ai, Putting 10,000+ Hours of Healthcare Sales Intelligence to Work on Every Deal

SAMI.ai embeds a decade of proven healthcare sales expertise into every call, helping teams close more deals, reduce sales risk, and build more predictable revenue.BOCA RATON, Fla., Sept. 1, 2026 /PRNewswire/ -- SalesSparx, the healthcare go-to-market acceleration firm, and Augment, the expert workflow company, today announced the general release of SAMI.ai, an AI sales performance system that puts more than 10,000 hours of healthcare sales intelligence to work across every sales conversation. T
Press release cover image

Sep 1, 2026

Press release

Beyond the Pad: Online Education Redefines the Fight Against Period Poverty

HARTFORD, Conn., Sept. 1, 2026 /PRNewswire/ -- For too long, conversations about Period Poverty have focused solely on whether someone can obtain a pad or tampon when needed. While that access is understandably at the center of the issue, it is only the starting point. For those on the frontlines of this crisis - healthcare providers, researchers, and community leaders - it is becoming increasingly clear that access is only the starting point in an overlooked determinant of health, education, ec